Raul Rodriguez
Chief Executive Officer en RIGEL PHARMACEUTICALS, INC. .
Fortuna: 3 M $ al 31/03/2024
Perfil
Raul R.
Rodriguez is currently the President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. He previously worked as the Executive Director-Business Development at Scios, Inc. from 1994 to 1997, and as the Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Mr. Rodriguez holds a graduate degree from the University of Illinois, an MBA from Stanford Graduate School of Business, and an undergraduate degree from Harvard College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
28/02/2024 | 2 036 629 ( 1.16% ) | 3 M $ | 31/03/2024 |
Cargos activos de Raul Rodriguez
Empresas | Cargo | Inicio |
---|---|---|
RIGEL PHARMACEUTICALS, INC. | Chief Executive Officer | 21/11/2014 |
Antiguos cargos conocidos de Raul Rodriguez.
Empresas | Cargo | Fin |
---|---|---|
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Chief Operating Officer | 01/03/2000 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01/03/1997 |
Formación de Raul Rodriguez.
University of Illinois | Graduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Harvard College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
RIGEL PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Health Technology |
- Bolsa de valores
- Insiders
- Raul Rodriguez